Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2012 | 06-2012 | 05-2012 | 03-2012 | 02-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7 | -8,332 | -4 | -3,572 | N/A |
| Depreciation Amortization | N/A | 38 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 1 | 89 | 1 | -111 | N/A |
| Other Working Capital | 1 | 83 | 1 | -189 | N/A |
| Other Operating Activity | 5 | 6,505 | 3 | 2,649 | 0 |
| Operating Cash Flow | $0 | $-1,618 | $0 | $-1,223 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | N/A | -3 | N/A |
| Purchase Sale Intangibles | N/A | -1,083 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,277 | 0 | -198 | 0 |
| Investing Cash Flow | $N/A | $-1,280 | $N/A | $-201 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 839 | N/A | 839 | N/A |
| Common Stock Issued | N/A | 2,045 | N/A | 541 | N/A |
| Other Financing Activity | 0 | 35 | 0 | 35 | 0 |
| Financing Cash Flow | $N/A | $2,919 | $N/A | $1,415 | $N/A |
| Beginning Cash Position | 4 | 10 | 4 | 10 | N/A |
| End Cash Position | 4 | 31 | 4 | 1 | N/A |
| Net Cash Flow | $0 | $21 | $0 | $-9 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -1,618 | 0 | -1,223 | N/A |
| Capital Expenditure | N/A | -4 | N/A | -3 | N/A |
| Free Cash Flow | 0 | -1,621 | 0 | -1,225 | 0 |